>>Signaling Pathways>> Neuroscience>> Cholecystokinin Receptor>>Loxiglumide (CR-1505)

Loxiglumide (CR-1505) (Synonyms: CR1505)

Catalog No.GC31382

록시글루마이드(CR-1505)는 콜레시스토키닌(CCK-1) 수용체 길항제이다.

Products are for research use only. Not for human use. We do not sell to patients.

Loxiglumide (CR-1505) Chemical Structure

Cas No.: 107097-80-3

Size 가격 재고 수량
10mM (in 1mL DMSO)
US$67.00
재고 있음
10mg
US$61.00
재고 있음
50mg
US$243.00
재고 있음
100mg
US$437.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Protocol Chemical Properties Product Documents Related Products

Loxiglumide is a cholecystokinin (CCK-1) receptor antagonist.

The effects of pancreatic rest by oral administration of CCK-1 receptor antagonist Loxiglumide and pancreas stimulation are investigated via endogenous CCK release induced by po protease inhibitor camostat on the recovery of pancreatic secretory function, and biochemical and histological changes of the pancreas after acute hemorrhagic pancreatitis. Oral administration of CCK-1 receptor antagonist Loxiglumide with a dose of 50 mg/kg body weight inhibits pancreatic exocrine secretion for more than 12 h. Thus, every 12-h administration of Loxiglumide might have completely blocks the effect of endogenously released CCK on the pancreas (pancreatic rest)[1].

[1]. Jia D, et al. Effect of endogenous cholecystokinin on the course of acute pancreatitis in rats. World J Gastroenterol. 2015 Jul 7;21(25):7742-53.

리뷰

Review for Loxiglumide (CR-1505)

Average Rating: 5 ★★★★★ (Based on Reviews and 36 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Loxiglumide (CR-1505)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.